Ventricular septal defect

New Philips Mini TEE ultrasound transducer helps improve cardiac care for more patients

Retrieved on: 
Wednesday, January 31, 2024
ICU, Surgeon, PHG, Workflow, Heart, Ventricular septal defect, AI, Catheter, 3D, Patient, Twilight anesthesia, Diagnosis, TEE, FDA, Columbia University, Mini, Echocardiography, Society, Physician, Risk, Cardiology, AEX, Detection, EPIQ, Medical imaging

Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer.

Key Points: 
  • Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer.
  • Announced today, Philips’ new X11-4t Mini 3D TEE transducer is shifting that balance and opening 3D TEE imaging to previously unaddressed patients [5].
  • “As a pioneer and leading innovator in cardiac ultrasound, our 3D ultrasound technology plays a critical role in many cardiac procedures.
  • The Philips X11-4t ultrasound transducer is scheduled for commercial availability in 2024 and is pending CE mark in Europe.

BrightHeart Welcomes Michael Butchko as an Independent Board Member

Retrieved on: 
Tuesday, January 30, 2024
Software, Other Health, Radiology, Data Management, Apps, Applications, Technology, Medical Devices, Artificial Intelligence, Health Technology, Cardiology, Biotechnology, Other Technology, Health, Ventricular septal defect, Senior, Pregnancy, Partner, Prenatal care, GE HealthCare, Medical imaging

BrightHeart, a Paris-based company developing an AI solution for the prenatal detection of congenital heart defects, announced today the appointment of Michael Butchko as an independent board director.

Key Points: 
  • BrightHeart, a Paris-based company developing an AI solution for the prenatal detection of congenital heart defects, announced today the appointment of Michael Butchko as an independent board director.
  • The BrightHeart AI solution assists clinicians with the identification of defects, offering a crucial window for early treatment of problems that could endanger a child's health.
  • Mr. Butchko brings more than 30 years of leadership experience and sectorial expertise to BrightHeart, along with a renowned reputation in the ultrasound space.
  • In his capacity as an independent board member, Mr. Butchko will provide objective insights, strategic guidance, and sectorial experience as BrightHeart gears up for its commercial launch.

St. Joseph's Children's Hospital First in Tampa Bay to Implant Leadless Pacemaker in Pediatric Heart Patient

Retrieved on: 
Friday, February 2, 2024
Partnership, Medicine, Ventricular septal defect, Leg, Life, Hospital, Child, Medtronic, Electrophysiology, Heart, Patient, Nissan Micra, Skin, Congenital heart block, Dizziness, Blood, Infection, Medical device

TAMPA, Fla., Feb. 2, 2024 /PRNewswire/ -- The Patel Children's Heart Institute at St. Joseph's Children's Hospital recently implanted its first leadless pacemaker, the first among all Tampa Bay hospitals to leverage this advanced technology in a pediatric patient.

Key Points: 
  • TAMPA, Fla., Feb. 2, 2024 /PRNewswire/ -- The Patel Children's Heart Institute at St. Joseph's Children's Hospital recently implanted its first leadless pacemaker, the first among all Tampa Bay hospitals to leverage this advanced technology in a pediatric patient.
  • The procedure was performed by Dr. Kelvin Lau, director of pediatric electrophysiology at St. Joseph's Children's Hospital, on a teenage girl who was born with isolated congenital heart block.
  • The Patel Children's Heart Institute at St. Joseph's Children's Hospital is home to the Tampa Bay area's only comprehensive congenital heart disease program.
  • A partnership between St. Joseph's Children's Hospital and UPMC Children's Hospital of Pittsburgh provides families across Florida with unprecedented access to the highest level of pediatric heart care available.

Alberta Children's Hospital Foundation chosen as charity partner of 2024 CPKC Women's Open

Retrieved on: 
Thursday, February 1, 2024
Partnership, Parent, Hospital, Golf Canada, Congenital heart defect, Ventricular septal defect, CPKC, Caregiver, AB, Country club, Tournament, LPGA, Anomaly, Prenatal care, Alberta Children's Hospital, Women's Open, Gold

CALGARY, AB, Feb. 1, 2024 /PRNewswire/ - Canadian Pacific Kansas City (CPKC) is proud to announce that Alberta Children's Hospital Foundation has been chosen as the primary charity partner for the 2024 CPKC Women's Open, to be held at the historic Earl Grey Golf Club from July 23 – 28, 2024.

Key Points: 
  • CALGARY, AB, Feb. 1, 2024 /PRNewswire/ - Canadian Pacific Kansas City (CPKC) is proud to announce that Alberta Children's Hospital Foundation has been chosen as the primary charity partner for the 2024 CPKC Women's Open, to be held at the historic Earl Grey Golf Club from July 23 – 28, 2024.
  • "CPKC is pleased to once again partner with the Alberta Children's Hospital through the 2024 CPKC Women's Open," said Keith Creel, CPKC President and CEO.
  • "By building on our first Women's Open partnership with Alberta Children's Hospital in 2016, we will leverage our community investment program, CPKC Has Heart, to help the youngest hearts across Alberta."
  • I know that golf fans and event enthusiasts will celebrate the CPKC Women's Open as a week-long festival experience that will leave a meaningful community legacy in support of the Alberta Children's Hospital Foundation."

MEDITWIN Brings Together French Science and Technology Excellence Around Virtual Twins for the Future of Medical Care

Retrieved on: 
Wednesday, January 24, 2024
Data Management, Other Science, Technology, Research, Telemedicine, Virtual Medicine, Manufacturing, Other Health, Apps, Applications, Oncology, Medical Devices, Health Technology, Hospitals, Biometrics, Cardiology, Other Technology, Biotechnology, Software, Health, Science, Electronic Design Automation, PRISM, Teaching hospital, Biology, Morphometrics, Artificial intelligence, Ventricular septal defect, ICM, Thorax, Living Brain, Molina Healthcare, Test management, INRIA, Cerebral atrophy, Foresight, Medicine, Cancer, Algorithm, Risk, Dravet syndrome, Diagnosis, Cardiovascular disease, System, Cardiac arrest, Epilepsy, SAFIR, Alzheimer's disease, Safety, Cognition, CHU, Metabolism, Neurology, Dassault Group, Public, Artificiality, IHU, Hypoplastic left heart syndrome, Mortality, Patient, EEG, Partnership, Consciousness, Ecosystem, Digital, Vascular dementia, PEPR, Biomarker, Medical imaging

MEDITWIN will offer virtual twins for medical practice, helping to improve the quality of care for safer, more accessible healthcare for all.

Key Points: 
  • MEDITWIN will offer virtual twins for medical practice, helping to improve the quality of care for safer, more accessible healthcare for all.
  • The MEDITWIN project will offer personalized virtual twins of organs, metabolism and cancer, for better diagnosis and treatment.
  • Seven new medical practices will be developed from the virtual twins, in neurology, cardiology and oncology.
  • The MEDITWIN public-private alliance is a major step forward, mobilizing the best of medicine, science and technology to serve future healthcare.

The Inner Circle Acknowledges, Divyakant B. Gandhi, MBBS, FRCS, FACS as a Distinguished Cardiothoracic Surgeon

Retrieved on: 
Monday, January 15, 2024
Student, Atrial fibrillation, Patient, University, Research, Medical college, FRCS, Health, Multimedia, Heart, Inner circle, Cardiothoracic surgery, Circulatory system, FACS, Royal, Elective surgery, Coronary artery disease, Medicine, Mentorship, General surgery, Lung cancer, Ohio State University, Quality of life, Royal college, Georgia Tech, American College, Intellectual property, Ventricular septal defect, McLaren Health Care Corporation, Parent, Doctor of Philosophy, Multiple, Education, Mitral valve, Lung, MBBS, Physician

Divyakant B. Gandhi is an international physician, innovative thinker, and leader in cardiac care.

Key Points: 
  • Divyakant B. Gandhi is an international physician, innovative thinker, and leader in cardiac care.
  • He has been in practice as a Heart, Lung & Vascular surgeon for over 35 years.
  • As a leader in the clinical setting, Dr. Gandhi is the Chief of Staff, Medical Director, and Chief of Cardiovascular & Thoracic Surgery at McLaren Greater Lansing.
  • Dr. Gandhi practices his specialty under the auspices of the Center for Cardiovascular and Thoracic Surgery in Detroit, MI.

Israeli Humanitarian Organization Celebrates Saving Its 7000th Child Amidst Wartime Crisis

Retrieved on: 
Thursday, January 11, 2024
Family, Wolfson Medical Center, Heart, Female, Catheter, Friends, Echocardiography, TEL, Child, Save a Child's Heart, Hospital, Save, Ventricular septal defect, Cardiology, Nursing

TEL AVIV, Israel, Jan. 11, 2024 /PRNewswire/ -- Save a Child's Heart (SACH), an Israeli humanitarian organization, marked a major milestone when it treated Kelvin, a 10-year-old from Kenya. Kelvin became Save a Child's Heart's 7,000th child saved by the volunteer Israeli doctors of SACH. 

Key Points: 
  • Save a Child's Heart, an international Israeli humanitarian organization, treated its 7,000th child in Israel, a 10-year-old boy from Kenya, while providing urgent medical care to casualties of tragic attacks in Israel.
  • TEL AVIV, Israel, Jan. 11, 2024 /PRNewswire/ -- Save a Child's Heart (SACH), an Israeli humanitarian organization, marked a major milestone when it treated Kelvin, a 10-year-old from Kenya.
  • Kelvin became Save a Child's Heart's 7,000th child saved by the volunteer Israeli doctors of SACH.
  • Kelvin said he was excited and proud to be the 7,000th child treated: "Being the 7,000th kid helped by Save a Child's Heart felt really good.

Know as They Grow How birth defects affect each stage of life

Retrieved on: 
Monday, January 8, 2024
CDC, Quality of life, Family, Ventricular septal defect, Pregnancy, Birth defect, Risk, Vitamin, Woman, Smoking, Mortality, Health, Diabetes, Intellectual, Prescription, Anencephaly, Genetics, Folate, Spina bifida, Mental health, Birth, Insurance, Prenatal care, COVID-19, Fever, Infection, Anatomical pathology, Infant, Growth, Child, Life, Birth control

Common birth defects include congenital heart defects, cleft lip, cleft palate and spina bifida.

Key Points: 
  • Common birth defects include congenital heart defects, cleft lip, cleft palate and spina bifida.
  • Genetics, behaviors and social and environmental factors can impact the risk for birth defects, and not all birth defects can be prevented.
  • Most doctors recommend women take 400 micrograms of folic acid every day before and during pregnancy to help prevent birth defects.
  • Being obese can increase your baby's chances of having birth defects like neural tube defects, heart defects and cleft palate.

Gabi SmartCare Obtains FDA Certification to Market Its Digital Pediatric Solutions in the United States

Retrieved on: 
Monday, January 8, 2024
Other Health, Mobile, Wireless, Family, Data Management, Consumer, Medical Devices, Technology, Hospitals, Children, Other Technology, FDA, Health, Associate, Food, Partnership, Pregnancy, Parent, Ageing, Trial of the century, Hospital, Certification, Columbia University, Ventricular septal defect, Traction, Infant, Patient, Diagnosis, Algorithm, Factorization of polynomials, Child, Life, Nursing

Gabi SmartCare, which has recently signed collaborations with more than 30 American hospitals, aims to become a leader in digital pediatric healthcare.

Key Points: 
  • Gabi SmartCare, which has recently signed collaborations with more than 30 American hospitals, aims to become a leader in digital pediatric healthcare.
  • Gabi SmartCare offers out-of-hospital medical monitoring of newborns and children thanks to its miniaturized monitoring bracelet and digital platform accessible to doctors.
  • This certification authorizes Gabi SmartCare to market its full solution, i.e.
  • For Jonathan Baut, CEO of Gabi SmartCare, "FDA certification of our solutions is the gateway to market our solution in the medical sector.

Owlet Transforms Infant Care with the Launch of Two FDA-Cleared Devices – Dream Sock® and BabySat™

Retrieved on: 
Monday, January 8, 2024
Women, Other Health, Parenting, Children, Telecommunications, Baby, Maternity, Software, Family, Medical Devices, Hospitals, Consumer, Data Management, Technology, Mobile, Wireless, General Health, FDA, Health, Apps, Applications, Entrepreneurship, Food, Caregiver, IOS, Mortality, Parent, Research, Babysitting, Insurance, Oxygen, Ventricular septal defect, OWLT, Sleep, Infant, Vital signs, De novo, Birth control

Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today announces the launch and availability of Dream Sock® and BabySat™ , two medical devices with recent clearances from the U.S. Food and Drug Administration (“FDA”).

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today announces the launch and availability of Dream Sock® and BabySat™ , two medical devices with recent clearances from the U.S. Food and Drug Administration (“FDA”).
  • Both innovations deliver real-time health insights with medical-grade accuracy and unprecedented advancements for at-home infant care.
  • These features are available to both existing and new Dream Sock users who opt to enable these features in the Dream App.
  • For more details on each device and to find out which product is the right choice for your family, visit www.owletcare.com .